Revenue

SUI Group's expanded loan to Bluefin isn't just a deal; it's a strategic maneuver to consolidate Sui's DeFi landscape and forge a new model for institutional investment.

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

Triller's audacious acquisition of a SpaceX stake sends its stock soaring, but can this high-stakes bet on a space giant save a company plagued by financial woes?

The chocolatier's dual openings signal growth, but a look at the books reveals a deeper story of strategic overhaul, franchisee faith, and a high-stakes pivot.

As construction firm JFB Holdings pivots to AI combat, its partner XTEND lands major defense deals, revealing a potent growth model for the autonomous age.

As Aritzia prepares its Q1 FY27 results, all eyes are on whether the fashion house can sustain its meteoric growth and defy a turbulent retail landscape.

Co-Dx's local-first strategy empowers communities against disease, but can this innovative public health play overcome the company's financial headwinds?

Atlantic International regained Nasdaq compliance, but its record revenue and massive new contracts can't hide the cautionary tale of a company stretched thin by global M&A.

Wheels Up partners with Surf Air Mobility, leveraging Palantir's AI to overhaul its operations, signaling a tech-driven transformation for luxury air travel.

As Abbott prepares its July 16th earnings report, all eyes are on more than just the balance sheet. It's a test of its post-acquisition strategy.

Nanox reports revenue growth but a shrinking cash pile and a stark warning about its future, forcing a strategic retreat from guidance amid legal troubles.

A new report reveals hotels injected $12B into San Francisco's economy. We dive into the public-private strategy driving this comeback and its ripple effect.

Awani Capital's merger of two roofing firms signals a major shift in home services, betting on a cash-only model to consolidate a fragmented, high-demand market.

Automotive tech giant Visteon announced a massive share repurchase, delighting Wall Street. But in an industry demanding relentless innovation, is this the best use of capital?

Freedom Holding Corp. secured a key S&P upgrade for its subsidiaries, bolstering its aggressive global expansion. But can its risk controls keep pace?

The lender's 10% yield attracts income investors, but a tight payout ratio and market shifts raise questions about its long-term sustainability.

Verano's upcoming Q2 report is a key indicator for the cannabis sector. We look at the strategic moves, from stock splits to rescheduling, setting the stage.

With its stock lagging despite strong sales, Insulet brings on a proven value-creator. Can the 'Mazelsky Playbook' accelerate growth and fend off rivals?

Beyond the press release, MegaGen's investment in BIOLASE is a strategic masterclass in post-acquisition revival, aiming to dominate the dental tech market.

A landmark acquisition is set to 4x IQSTEL's net income. But the real story is its pivot from a low-margin carrier to a high-margin digital services powerhouse.